Stockscreener 앱 받기
13.12
3.46%
-0.47
시간 외 거래:
13.00
-0.12
-0.91%
전일 마감가:
$13.59
열려 있는:
$13.66
하루 거래량:
151.87K
Relative Volume:
0.49
시가총액:
$281.13M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-16.40
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
-0.61%
1개월 성능:
+6.23%
6개월 성능:
+151.82%
1년 성능:
+30.29%
1일 변동 폭
$13.10
$13.66
1주일 범위
$12.55
$14.06
52주 변동 폭
$3.78
$15.71
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
13.12 | 281.13M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
282.61 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
59.18 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
59.31 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
101.28 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.67 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX) - Yahoo Finance
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of America Corp DE - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Shares Purchased by Bank of America Corp DE - Defense World
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Kalkine : indexnasdaq ixic OptimizeRx Drives Healthcare Tech Communication Shift - Kalkine Media
OptimizeRx (NASDAQ:OPRX) Given New $16.00 Price Target at Stifel Nicolaus - Defense World
OptimizeRx (OPRX) Price Target Raised by Stifel Analyst | OPRX S - GuruFocus
OptimizeRx (OPRX) Price Target Raised by Stifel to $16 | OPRX St - GuruFocus
Stifel raises OptimizeRX stock price target to $16 from $12 By Investing.com - Investing.com South Africa
Stifel raises OptimizeRX stock price target to $16 from $12 - Investing.com
OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Squarepoint Ops LLC - Defense World
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy - sharewise
OptimizeRx Corp (OPRX) Stock Price Up 6.89% on Jun 5 - GuruFocus
New Strong Buy Stocks for June 4th - TradingView
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Jane Street Group LLC Raises Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
BNP Paribas Financial Markets Grows Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Northern Trust Corp Purchases 6,043 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Corp (OPRX) Shares Gap Down to $12.125 on May 28 - GuruFocus
Sherbrooke Park Advisers LLC Sells 22,429 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
D. E. Shaw & Co. Inc. Purchases 32,062 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx’s SWOT analysis: digital health firm’s stock faces growth hurdles - Investing.com
Tang Capital Management LLC Invests $1.08 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
AWM Investment Company Inc. Has $1.05 Million Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
D. E. Shaw & Co. Inc. Raises Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain? - sharewise
Dimensional Fund Advisors LP Boosts Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates - MSN
OptimizeRx Corp (OPRX) Stock Price Up 4.11% on May 19 - GuruFocus
JMP Securities Increases OptimizeRx (NASDAQ:OPRX) Price Target to $14.00 - MarketBeat
OptimizeRx Corp (OPRX) Shares Up 5.92% on May 16 - GuruFocus
OptimizeRx to Participate in Upcoming Investor Conferences - The Manila Times
OptimizeRx Sets Ambitious Investor Relations Schedule: 4 Major Conferences Including William Blair and B. Riley - Stock Titan
JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $14.00 - Defense World
Dimensional Fund Advisors LP Raises Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
G2 Investment Partners Management LLC Sells 109,041 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Price Target Raised by B. Riley Amid Strong Q1 Performance | OPRX Stock News - GuruFocus
OptimizeRx First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
OptimizeRx (OPRX) Price Target Boosted to $22 by Roth Capital | - GuruFocus
Barclays PLC Boosts Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Wells Fargo & Company MN Purchases 2,797 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx (OPRX) Stock Target Price Raised by JMP Securities | - GuruFocus
OptimizeRX stock target raised to $14 by JMP Securities - Investing.com Nigeria
OPTIMIZERx earnings beat by $0.20, revenue topped estimates - Investing.com Canada
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Optimizerx Corp 주식 (OPRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
| Stelmakh Edward | CFO/COO |
Oct 11 '24 |
Option Exercise |
0.00 |
8,222 |
0 |
35,432 |
1.70%
0.26%
자본화:
|
볼륨(24시간):